JP Stock MarketDetailed Quotes

4553 TOWA Pharmaceutical

Watchlist
  • 3045
  • -10-0.33%
20min DelayMarket Closed Jul 24 15:00 JST
156.87BMarket Cap9.27P/E (Static)

TOWA Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TOWA Pharmaceutical Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

May 14, 2024

Revenue(YoY)

59.61B

-12.92%
EPS(YoY)

94.56

+2049.09%
Analyst Rating

Strong Buy

Jul 2, 2024

TOWA Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 59.733B--
Aug 8, 20242025/Q1-- / 61.500B--
May 14, 20242024/Q459.609B / 61.606B--
Feb 13, 20242024/Q360.929B / 55.735B--
Nov 13, 20232024/Q252.848B / 52.584B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 59.733B--
Aug 8, 20242025/Q1-- / 61.500B--
May 14, 20242024/Q459.609B / 61.606B--
Feb 13, 20242024/Q360.929B / 55.735B--
Nov 13, 20232024/Q252.848B / 52.584B--

Unlock Free Earnings Estimates

TOWA Pharmaceutical Earnings Reports

  • TOWA Pharmaceutical: Confirmatory letter.

    Jul 10 03:04 ET

  • TOWA Pharmaceutical: Corrected Financial Report - 68th Term (2023/04/01 - 2024/03/31)

    Jul 10 03:00 ET

  • TOWA Pharmaceutical: Extraordinary Report

    Jun 26 23:54 ET

  • TOWA Pharmaceutical: Securities Report - 68th Period (April 1, 2023 - March 31, 2024)

    Jun 25 20:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 2, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      0.00%

    • Hold

      25.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg